만성폐쇄성폐질환 환자에서 호흡곤란과 영상학적 정량과의 상관관계 = The Correlation of Dyspnea and Radiologic Quantity in Patients with COPD

국문 초록 (Abstract)

연구배경: COPD에서 보이는 호흡곤란의 주된 원인이 폐의 과팽창이고 이 과팽창을 치료하는 것이 호흡곤란의 향상에 중요한 것으로 밝혀지고 있다. 그러나 FEV1, FVC만으로는 호흡곤란의 정도와 과팽창을 정확히 측정할 수 없다. 따라서 단순 흉부 방사선에서 관찰되는 폐의 과팽창의 정도와 고해상도흉부 단층촬영에서 폐기종의 정도가 호흡곤란을 객관적으로 알 수 있는 지표가 되는 지를 알아보고자 하였다. 방법: COPD로 진단 받은 50명(평균 연령 69세, 남자 47명, 여자 3명)을 대상으로 하였다. 폐의 종축, 흉골 뒤 공간, 횡격막의 높이를 각각 측정하여 총 0에서부터 3까지로 폐의 과팽창 정도(chest score)를 측정하였고, 고해상도 흉부단층 촬영에서 폐기종의 정도(HRCT score)를 구하여 이를 환자의 호흡곤란의 정도 및 폐용적 검사를 비롯한 폐기능 검사와의 상관관계를 구하였다. 결과: 호흡곤란의 지수(Borg scale)는 폐기능 검사의 지표인 FVC, FEV1, FEV1/FVC, RV, RV/TLC, DLCO와 유의한 상관관계가 관찰되었다. Borg scale은 HRCT score와 상관관계가 있었으나, chest score와는 상관관계가 없었다. 그리고 Borg scale은 체질량 지수와 역 상관관계가 있었다. 결론: 고해상도 흉부 단층촬영의 폐기종의 정도는 COPD 환자에서 호흡곤란의 정도를 알 수 있는 객관적 지표가 될 수 있다.

다국어 초록 (Multilingual Abstract)

Background: A lung hyperinflation, or air trapping, caused by expiratory flow-limitation contributes to dyspnea in patients with chronic obstructive pulmonary disease (COPD). Forced expiratory volume in 1 second (FEV1) has served as an important diagnostic measurement of COPD, but does not correlate with patient-centered outcomes such as dyspnea. Therefore, this study was performed to investigate the role of radiologic quantity in evaluating the dyspnea in patients with COPD by measuring lung hyperinflation in chest x-ray and high resolution chest tomography (HRCT). Methods: Fifty patients with COPD were enrolled in this study. Their subjective dyspnea score (modified Borg scale dyspnea index), spirometry, and lung volume were measured. Simultaneous hyperinflations of chest x-ray score (chest score) and degree of emphysema of HRCT (HRCT score) were measured. The chest score were composed of lung length, retrosternal space width, and height of the arc of the diaphragm and HRCT score were composed of severity and extent of emphysema. Results: The mean age of patients was 69 years old and their mean FEV1 was 51.7%. The Borg score significantly correlated with parameters of spirometry and lung volume, including FVC, FEV1, FEV1/FVC, RV, RV/TLC, and DLCO. The Borg score correlated well with HRCT score, but did not correlate with chest score. Also, the Borg scale correlates inversely with body mass index. Conclusion: The quantity of emphysema on chest HRCT may serve as an objective marker of dyspnea in patients with COPD.

참고문헌 (Reference)

1 Agust AG, "Weight loss in chronic obstructive pulmonary disease. Mechanisms and implications" 15 : 425-432, 2002

2 Celli BR, "The importance of spirometry in COPD and asthma: effect on approach to management" 117 : 15S-19S, 2000

3 Celli BR, "The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease" 350 : 1005-1012, 2004

4 Nicklaus TM, "The accuracy of the roentgenologic diagnosis of chronic pulmonary emphysema" 93 : 889-899, 1966

5 American Thoracic Society, "Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease" 152 : S77-S121, 1995

6 American Thoracic Society, "Standardization of spirometry, 1994 update" 152 : 1107-1136, 1995

7 Pratt PC, "Role of conventional chest radiography in diagnosis and exclusion of emphysema" 82 : 998-1006, 1987

8 Rothpearl A, "Radiographic measures of hyperinflation in clinical emphysema. Discrimination of patients from controls and relationship to physiologic and mechanical lung function" 94 : 907-913, 1988

9 Sakai F, "Pulmonary function abnormalities in patients with CT-determined emphysema" 11 : 963-968, 1987

10 Borg GA, "Psychophysical bases of perceived exertion" 14 : 377-381, 1982

11 Kim DS, "Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey" 172 : 842-847, 2005

12 Parker CM, "O'Donnell DE. Physiological changes during symptom recovery from moderate exacerbations of COPD" 26 : 420-428, 2005

13 Mahler DA, "Mechanisms and measurement of dyspnea in chronic obstructive pulmonary disease" 3 : 234-238, 2006

14 Stevenson NJ, "Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease" 172 : 1510-1516, 2005

15 van Schayck CP, "Is lung function really a good parameter in evaluating the long-term effects of inhaled corticosteroids in COPD?" 15 : 238-239, 2000

16 Rabe KF, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary" 176 : 532-555, 2007

17 Pauwels RA, "Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary" 163 : 1256-1276, 2001

18 Wegner RE, "Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD" 7 : 725-729, 1994

19 O'Donnell DE, "Exertional breathlessness in patients with chronic airflow limitation. The role of lung hyperinflation" 148 : 1351-1357, 1993

20 Nishimura K, "Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD" 121 : 1434-1440, 2002

21 Reich SB, "Correlation of radiographic measurements and pulmonary function tests in chronic obstructive pulmonary disease" 144 : 695-699, 1985

22 Nakano Y, "Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function" 162 : 1102-1108, 2000

23 Expert panel on the identification, evaluation, and treatment of overweight in adults, "Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary" 68 : 899-917, 1998

24 Lopez AD, "Chronic obstructive pulmonary disease: current burden and future projections" 27 : 397-412, 2006

25 The COPD Guidelines Group of the Standards of Care Committee of the BTS, "BTS guidelines for the management of chronic obstructive pulmonary disease" 52 (52): S1-S28, 1997

26 Boschetto P, "Association between markers of emphysema and more severe chronic obstructive pulmonary disease" 61 : 1037-1042, 2006

27 Murray CJ, "Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study" 349 : 1498-1504, 1997

28 Mahler DA, "A factor analysis of dyspnea ratings, respiratory muscle strength, and lung function in patients with chronic obstructive pulmonary disease" 145 : 467-470, 1992